================================================================================
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported) April 20, 2004
PhotoMedex, Inc.
------------------------------------------------------
(Exact name of registrant as specified in its charter)
Delaware 0-11635 59-2858100
- ---------------------------- ---------------- -------------------
(State or other jurisdiction (Commission File (IRS Employer
of incorporation) Number) Identification No.)
147 Keystone Drive, Montgomeryville, PA 18936
- ---------------------------------------- ----------
(Address of principal executive offices) (Zip Code)
Registrant's telephone number, including area code 215.619.3600
------------------------------------------------------------
(Former name or former address if changed since last report)
================================================================================
Item 9. Regulation FD Disclosure
- ----- ------------------------
On April 20, 2004, the Registrant announced that WellPoint, a
private health plan, had approved for reimbursement procedures using
the XTRAC(R) excimer laser to treat psoriasis.
The Information contained herein and in the accompanying exhibit
shall not be incorporated by reference into any filing of the
Registrant, whether made before or after the date hereof, regardless
of any general incorporation language in such filing, unless
expressly incorporated by specific reference to such filing. The
information in this report, including the exhibit hereto, shall not
be deemed to be "filed" for purposes of Section 16 of the Securities
Exchange Act of 1934, as amended, or otherwise subject to the
liabilities of that section or Sections 11 and 12 (a) (2) of the
Securities Act of 1933, as amended.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the
Registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
PhotoMedex, Inc.
Date: April 21, 2004 By: /s/ Dennis M. McGrath
-----------------------
Chief Financial Officer
EXHIBIT INDEX
Exhibit No. Subject Matter Press release of PhotoMedex, Inc.
99.1
PhotoMedex Press Release dated April 20, 2004, reporting the announcement that
WellPoint Adopts Reimbursement for PhotoMedex XTRAC(R)